Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105729 · ClinicalTrials.gov registry record · NA
Substance Abuse Self-Help Group Referral: Outcomes and Services Use
A NA study of Substance Use Disorders, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 345
- Enrollment target
- 1
- Study location
NCT00105729: Completed NA study of Substance Use Disorders, sponsored by US Department of Veterans Affairs.
NCT00105729 is a NA study of Substance Use Disorders that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 345 participants, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105729, a NA study of Substance Use Disorders, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 345 participants
- Enrollment target
- 1
- Study location
Study Summary
Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.
Conditions Studied
Interventions
- BEHAVIORAL Intensive referral to 12-step self-help groups
Study Locations (1)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 345 participants |
| Start Date | 2003-01 |
| Est. Completion | 2005-04 |
| Phase | NA |
What the finished NCT00105729 record still lists
NCT00105729 is an interventional study that assigns participants to a tested intervention. The registered 345 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (30% lower).
The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Intensive referral to 12-step self-help groups is the first listed.
NCT00105729 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00105729 about?
NCT00105729 is a clinical study titled "Substance Abuse Self-Help Group Referral: Outcomes and Services Use". Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.
What is the current status of trial NCT00105729?
This trial is currently completed. It is a NA study. The enrollment target is 345 participants. The study started on 2003-01. Estimated completion is 2005-04.
What conditions does trial NCT00105729 study?
This clinical trial studies the following conditions: Substance Use Disorders.
What interventions are being tested in trial NCT00105729?
The interventions under investigation include: Intensive referral to 12-step self-help groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT00105729?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00105729 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00105729's enrollment target sits among peer trials
345 15th of 93 higher than 79 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- NCT05107674 · 345 participants · Phase 1
A Study of NX-1607 in Adults With Advanced Malignancies
- NCT05700279 · 345 participants · NA
Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset
- NCT05781100 · 345 participants · NA
Investigating Baby Behavior and Family Technology Use Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia